The human colon carcinoma cell lines Caco-2 and HT-29 take up on taurine uptake. In accordance with this suggestion, treatment of Caco-2 cells with cholera toxin, which elevated intracellular cAMP levels, was found to inhibit taurine uptake. The steady state levels of the taurine transporter mRNA transcripts were not altered as a result of STa treatment.
Introduction
The heat-stable enterotoxin (STa)1 produced by certain strains of Escherichia coli is an 18-or 19- induces rapid water and electrolyte secretion in the intestine. It is one of the most frequent diarrheagenic agents, particularly in infants and travelers (1, 2) . The mechanism of STa action on intestinal fluid balance has been investigated in recent years but is not yet fully understood. STa binds to specific receptors in the intestinal brush border membrane (3) (4) (5) and activates guanylate cyclase (6) . The intestinal membrane-bound guanylate cyclase which is activated by the toxin has itself been shown to be the receptor for the toxin (7, 8) . Activation of guanylate cyclase by STa leads to a profound increase in the intracellular levels of guanosine 3',5'-cyclic monophosphate (cGMP) in enterocytes (5, 6, 9) . As a second messenger, cGMP might activate protein kinase G and/or protein kinase A (10) (11) (12) and affect ion transport mechanisms. In particular, STa inhibits Na' and C1-absorption and stimulates CF-secretion in the intestine (6, 9, 10, 13 ). This cascade is considered as the likely pathway by which STa impairs the intestinal fluid balance in vitro and in vivo (6, (9) (10) (11) (12) (13) (14) . Interestingly, it has been found that STa mimics naturally occurring, endogenous activators of the intestinal guanylate cyclase. The first identified physiological ligand for the "STa-receptor" was the 15-amino acid peptide guanylin ( 15 ) . Guanylin has been shown to displace STa from its binding sites, activate guanylate cyclase (15) (16) (17) (18) and stimulate Clsecretion in human intestinal cells (19) . Guanylin appears to be less potent than STa. However, a more potent member of this peptide family, uroguanylin, which might be a regulatory signal for ion transport in-renal tissue, has been recently identified (20) .
Until now, studies on the pathophysiological role of cGMP in intestinal function have been mostly focused on the influence of this cyclic nucleotide on ion transport. There is very little information available on the role of cGMP in the intestinal absorption of nutrients other than electrolytes. The present study was undertaken to investigate the effects of STa and guanylin, and thereby of cGMP, on the intestinal absorption of a unique amino acid, taurine. Though this amino acid is not incorporated into proteins and is known to participate in only very few metabolic reactions, it is the most abundant free amino acid in many tissues. Available evidence indicates that taurine might participate in a variety of cellular functions (21) and even be an essential nutrient during development (22) . The nutritional needs for this amino acid in man and in animals are met mainly by intestinal absorption from dietary sources. Absorption of taurine in the intestine occurs via a transport system that is specific for taurine and other ,/-amino acids (23) . The characteristics of the taurine transporter expressed in the intestinal brush border membrane have been studied in detail (24) (25) (26) (27) (28) .
the activity of the taurine transporter is regulated by protein kinase C (30). In the present investigation, we have used these cell lines to study the influence of STa and guanylin on the activity of the intestinal taurine transporter. The results of this investigation reveal that STa and guanylin increase intracellular levels of cGMP in Caco-2 cells but not in cells and that the elevation of cGMP levels in Caco-2 cells is associated with a significant decrease in the activity of the taurine transporter.
Methods
Cell culture. Caco-2 cells were routinely cultured in 75-cm2 collagentreated (calf skin collagen type I, 5 .g/cm2) culture flasks with MEM supplemented with 10% FBS, penicillin (100 U/ml), streptomycin (100 Hg/ml), and 1% nonessential amino acid solution. The cells were maintained at 370C and 5% CO2. Subconfluent cultures were treated with PBS containing 0.25% trypsin and 0.5 mM EDTA. Subcultures were started from the released and washed cells. For FBS, penicillin (100 U/ml) and streptomycin (100 jsg/ml). It contained D-glucose at a concentration of 4.5 grams/liter. Cells were seeded in untreated 35 -mm dishes at a density of 1.5x 106 cells/dish and used for uptake measurements at full confluence on the 4th or 5th day after seeding.
Cell treatments. Stock solutions of compounds were prepared in deionized water or DMSO. Cultured cells were preincubated in the respective media at 37°C and 5% CO2 with desired concentrations of STa (mostly 50 nM), guanylin (5 uM), cGMP-analogues (1 mM), cholera toxin (100 ng/ml), or protein kinase inhibitors for desired time periods.
Uptake measurements. Uptake of taurine and other amino acids by Caco-2 cells cultured on plastic dishes was measured at room temperature as described earlier (30, 32, 33 MgSO4, 5 glucose, and radiolabeled amino acids, glucose or glycylsarcosine (Gly-Sar). In some experiments, STa was also added to the uptake buffer. After incubation for a desired time period, the buffer was removed and the cells were quickly washed four times with ice-cold uptake buffer. 1 ml of 0.2 M NaOH containing 1% SDS was added to each dish, and the radioactivity of the contents from the dishes was measured by liquid scintillation spectrometry.
The uptake buffer was modified in some experiments. For the measurement of glucose uptake, the wash and uptake buffers contained glucose at a concentration of 100 AM instead of 5 mM. To determine the effect of ST, on the proton-dependent peptide transport in Caco-2 cells, a pH 6.0 buffer in which Hepes was replaced by Mes was used.
For the measurement of taurine uptake in the absence of sodium or chloride, KC1 and Assay of cGMP and cAMP. Caco-2 and HT-29 cells were cultured for 4 d. The cGMP-as well as cAMP-levels were measured as previously described (34) in control and STa-or cholera toxin-treated cells. In brief, confluent cell layers were incubated for 15 min at room temperature in the uptake buffer (pH 7.5) containing 1 mM 3-isobutyl-1-methylxanthine (IBMX) and then exposed to STa (50 nM) for 5 min or to cholera toxin (100 ng/ml) for 4 h in the presence of 1 mM IBMX. After this treatment, the cells were washed once with ice-cold buffer containing 1 mM IBMX. Cells were then lysed by incubating the cell layer in 1 ml of 0.1 N HCl for 30 min. The acid extract was 'collected and used for measurement of cGMP and cAMP. Radioimmunoassay of these cyclic nucleotides was performed using the Gammaflow automated radioimmunoassay system (Atto Instruments, Inc., Potomac, MD) (34) .
mRNA isolation and Northern analysis. Caco-2 cells were cultured in 225-cm2 culture flasks for 5 d to full confluence. Treatment was performed in these flasks in the respective media at 37°C and 5% CO2 with or without STa (50 nM) for 30 min. Following this treatment, the cell layers were washed twice with ice-cold PBS. Poly(A)+ RNA from these cells was isolated using the FastTrack mRNA isolation kit (Invitrogen, San Diego, CA). Size-fractionation of mRNA and Northern analysis were performed as described (35) . A 705-bp fragment of the coding region of the human placental taurine transporter cDNA (36) 
Results
Effect of E. coli STa and guanylin on taurine uptake in HT-29 and Caco-2 cells. We have previously shown that HT-29 cells as well as Caco-2 cells possess taurine transport activity (29, 30). A transport system responsible for taurine uptake has been characterized in HT-29 cells (29). These studies have established that the uptake of taurine in HT-29 cells occurs via a Na+-and Cl --coupled transporter which is specific for taurine and other S-amino acids. The taurine uptake system expressed in Caco-2 cells has not been studied in detail. Fig. 1 describes the time-dependent uptake of taurine and the influence of Na'
and Cl-on the uptake process in Caco-2 cells. The uptake was found to be linear at least up to 10 min. The intracellular concentration of taurine, calculated by using a value of 3.6 JA/ mg of protein for the intracellular volume (37, 38) , was 225 nM after 20 min incubation while the concentration of taurine in the extracellular medium was 40 nM. These data show that Caco-2 cells are capable of transporting this amino acid against a concentration gradient as has been previously shown for HT-29 cells. The uptake of taurine in Caco-2 cells was found to be dependent on the presence of both Na+ and Cl-in the uptake medium. The presence of either Na+ or Cl-alone was unable to support taurine uptake. In the absence of both Na+ and Clthe taurine uptake was similar to that in the absence of Na'.
Thus, the uptake of taurine in Caco-2 cells is mediated by a Na+-and Cl--coupled transporter. We also performed this experiment at a taurine concentration of 1 gM and found that the uptake was obligatorily dependent on Na' and Cl-even under these conditions. In another series of experiments, we studied the effect of culture time (4-10 d) of the cells on the taurine uptake and on the magnitude of the STa effect. The experiments revealed, as already described in a former publication (30), that with increasing number of days after confluence the specific taurine transport activity decreases. In these experiments the taurine transport declined continuously to 67% at day 10 compared to transport at day 4. However, treatment with STa (50 nM, 30 min) inhibited the taurine transport by 30-45% and the rate of inhibition did not correlate with the age of the monolayers.
Influence of treatment time and STa concentration on taurine uptake in Caco-2 cells. The STa-induced inhibition of taurine uptake in Caco-2 cells was very rapid. Even when the cells had not been treated with the toxin before uptake and the toxin was present in the medium only during the 10-min uptake period, the uptake of taurine was found to be inhibited by 15%. A similar extent of inhibition was observed when STa was added to the medium and immediately removed before initiating uptake measurement. The influence of treatment time on STa-induced inhibition of taurine uptake was therefore studied by incubating the cells with STa (50 nM) for varying periods of time (2.5-60 min), followed by removal of the toxin before initiation of uptake measurement (Fig. 2 A) . Cells which were treated similarly but in the absence of STa served as controls. The STa- (Fig. 3) . The experimental data were transformed into a linear format by the Eadie-Hofstee method. Linear plots (uptake rate vs. uptake rate/taurine concentration) with regression coefficients of -0.982 (control) and -0.995 (STa), respectively, were obtained thus supporting the involvement of a single transport system (Fig. 3, inset) . Moreover, the data show that STa elicited alterations in the maximal velocity of taurine transport as well as in the affinity of the transporter for taurine. In control cells, the apparent Michaelis- (Fig. 4) . The cGMP levels in HT-29 cells which have been treated with STa under identical conditions remained absolutely unaffected (Fig. 4 A) . There was no significant change in the intracellular levels of cAMP in both Caco-2 and HT-29 cells as a result of treatment with STa (Fig. 4 B) .
Influence of cGMP analogues on taurine uptake. The apparent association between the inhibition of taurine uptake by ST. Effect ofprotein kinase inhibitors on the inhibition of taurine uptake induced by STa. We then investigated the effect of protein kinase inhibitors on the STa-induced inhibition of taurine uptake. First, Caco-2 cells were treated with or without STa (50 nM) in the absence or presence of staurosporine (500 nM).
Measurement of taurine uptake in these cells revealed that STa inhibited taurine uptake by 35%, whereas staurosporine increased it by 100% (Fig. 5) . When cells were treated with STa and staurosporine together, taurine uptake was the same as that in cells treated with staurosporine alone. This shows that staurosporine itself increases the taurine uptake and that it blocks the effect of STa completely. However, staurosporine is a relatively nonselective protein kinase inhibitor that might inhibit protein kinase A, protein kinase G, and protein kinase C under the experimental conditions described. In order to identify the protein kinase involved in the mediation of the STa effect, we tested a selective protein kinase A inhibitor (H-89), a selective protein kinase G inhibitor (KT5823) and a selective protein kinase C inhibitor (chelerythrine) for their ability to block the effect of STa (Fig. 5) . Treatment of Caco-2 cells with H-89 alone for 2 h caused a significant inhibition of taurine uptake (33% at a concentration of 30 ,uM). STa, which inhibited taurine uptake by 33% when incubated alone with the cells, failed to inhibit the uptake if H-89 was present during the treatment. Thus, the selective protein kinase A inhibitor was able to block completely the inhibitory effect of STa. Treatment of Caco-2 cells with the protein kinase G inhibitor KT5823 also caused a significant inhibition of taurine uptake (32% at a concentration of 15 ,M). STa inhibited taurine uptake by 39% when incubated alone with the cells but it also inhibited the uptake (31%) when KT5823 was present before and during the treatment. Thus, the selective protein kinase G inhibitor was unable to block the inhibitory effect of STa on taurine uptake. The experiments with the protein kinase C inhibitor chelerythrine also showed a similar pattern. Chelerythrine by itself (15 MM) inhibited the taurine uptake by 30%. STa inhibited the uptake of taurine by 34% in these experiments. However, a similar inhibition (40%) by STa was observed when the cells were cotreated with chelerythrine and STa. These results indicate that protein kinase G as well as protein kinase C are not involved in the inhibition of taurine uptake induced by STa and that protein kinase A mediates the STa effect most likely by cross-activation of the kinase by increased levels of cGMP. Interestingly, treatment of the cells with the protein kinase inhibitors alone had significant effects on taurine uptake. The stimulation caused by staurosporine can be explained, at least in part, by its ability to block the inhibitory influence of protein kinase C (30) and protein kinase A (see below) on the taurine transporter activity. The reasons for the observed inhibition of taurine uptake by other protein kinase inhibitors (H-89, chelerythrine, and KT5823) are not known. Influence of cholera toxin on taurine uptake in Caco-2 cells. We then investigated the effect of cholera toxin, an agent known to increase intracellular cAMP levels, on taurine uptake in Caco-2 cells. Treatment of the cells with the toxin (100 ng/ml) for 4 h caused 51% inhibition of taurine uptake (Fig. 6 A) . This inhibition was accompanied by a 118-fold increase in the intracellular levels of cAMP (Fig. 6 B) . Cholera toxin treatment had only a small effect on cGMP levels. These data clearly show that activation of protein kinase A leads to inhibition of taurine uptake in Caco-2 cells.
Influence of STa on steady state levels of taurine transporter mRNA transcripts in Caco-2 cells. To determine whether the STa-induced inhibition of taurine uptake in Caco-2 cells is associated with any change in the levels of the taurine transporter mRNA, Northern analysis was carried out. The presence of a major hybridizing mRNA species, 6.9 kb in size, was evident in control cells as well as in STa-treated cells, but STa treatment had no effect on the levels of this transcript (data not shown).
Thus, the inhibition of taurine uptake induced by STa in Caco-2 cells is not accompanied by any change in the steady state levels of the taurine transporter mRNA. These studies were done using the human placental taurine transporter cDNA as the probe. There is evidence that a mRNA transcript with an identical coding region is expressed in Caco-2 cells and in human small intestine (unpublished data). It is not known at this time whether this transcript codes for the brush border or the basolateral taurine transporter. However, it should be noted that the functional characteristics of the cloned placental taurine transporter are very similar to those of the taurine transporter described in intestinal brush border membrane vesicles, making it highly possible that the 6.9-kb transcript identified by the placental probe is related to the apical taurine transporter in Caco-2 cells. Effect of STa on taurine uptake in Caco-2 cells cultured on permeable filters. Caco-2 cells grown on permeable cell culture inserts for 14 to 17 d form a differentiated monolayer. The integrity of the cell monolayer was confirmed microscopically, by measuring the transepithelial resistance and by measuring the transepithelial flux of inulin. Under the conditions described, the transepithelial resistance of the Caco-2 cell monolayers at the time of the uptake experiments (14 to 17 d of culture) was 639±11 Q X cm2 (n=18, range 554 to 719 Q x cm2). The transepithelial ['4C]inulin flux through the Caco-2 cell monolayers was less than 0.1%/h. We studied taurine uptake from the apical as well as from the basolateral side. As shown in Fig. 7 , the basolateral uptake was found to be 35% lower than that from the apical side. To address the question of polarity, i.e., from which side the toxin elicits its effect, we treated the Caco-2 cell monolayers either in the apical or in the basolateral medium with STa (200 nM) for 1 h. Treatment with STa at the apical side inhibited the apical taurine uptake by 31% (P = 0.0014). The basolateral taurine uptake was not affected by STa. Moreover, STa elicits its effect mainly from the apical side.
When treatment with STa was done on the basolateral side, there was only a small (14%) but statistically insignificant (P = 0.06) inhibition of the apical taurine uptake.
Discussion
In the present investigation, we focused on the role of cGMP in the modulation of taurine transport activity in the colon carci--noma cell lines, Caco-2 and HT-29. This cyclic nucleotide has been shown to be one of the three primary agents, the other two being cAMP and Ca2+, which regulate absorption/secretion of electrolytes in the intestine (39 were washed and uptake buffer containing taurine (60 nM) was added either to the apical or to the basolateral compartment of the filter inserts. Uptake was measured using a 10-min incubation time at room temperature. Values are means±SEM. n =9-11 (apical uptake) or 7 (basolateral uptake).
to inhibit taurine transport in HT-29 cells is explained by the observation that the toxin failed to alter cGMP levels in this cell line. The presence of the membrane-bound guanylate cyclase, the cellular receptor for the enterotoxin, has been demonstrated in Caco-2 cells (5). The HT-29 cells apparently lack the membrane-bound guanylate cyclase that is activatable by STa. However, since cGMP analogues were unable to inhibit the taurine uptake in these cells, it appears that some other cellular components involved in the biological effects of cGMP are also altered in these cells.
Since STa failed to affect taurine transport activity in HT- The inhibition of taurine uptake is not a nonspecific effect because under identical conditions uptake of several other nutrients remains unaffected. Kinetic analysis reveals that the STainduced inhibition is associated with a decrease in the VM",, and also with an increase in the K,. There is however no change in the steady state levels of the taurine transporter mRNA transcripts. The changes seen in the kinetic parameters of the taurine transport activity as a result of treatment with STa thus appear to be due to posttranscriptional events. Intracellular cGMP is involved in the initiation of these events because the STa effect is accompanied by an increase in cGMP levels. In HT-29 cells where there is no increase in cGMP levels as a result of treatment with STa, the toxin has no effect on taurine uptake. These data clearly indicate a role for cGMP in the STa-induced inhibition of the taurine transport activity in Caco-2 cells.
This study also presents evidence for the regulation of the taurine transporter in Caco-2 cells by the endogenous peptide guanylin. The influence of guanylin on the taurine transporter is the same as that of STa. Guanylin is known to be an endogenous agonist for the membrane-bound guanylate cyclase, and therefore it is most likely that the effect of guanylin on the taurine transporter activity in Caco-2 cells is also mediated by cGMP. This constitutes the first report on the regulation of an organic solute transport system by this endogenous peptide. These studies raise the possibility that guanylin may play a significant role in the regulation of intestinal transport of not only ions but also other nutrients as well.
The exact mechanisms by which cGMP inhibits the activity of the taurine transporter in Caco-2 cells remains speculative at this time. cGMP could activate protein kinase G that might phosphorylate the transporter protein resulting in the inhibition of its catalytic activity. cGMP might also activate protein kinase A by directly interacting with the enzyme. Even though the affinity of protein kinase A for cGMP is much lower than for cAMP, high levels of cGMP might compensate for this low affinity and cause activation of protein kinase A to a significant extent. There are several lines of evidence in support of this hypothesis. Only staurosporine, which is a nonspecific inhibitor of protein kinases, and H-89, which is a specific inhibitor of protein kinase A, are able to block the ST. effect. The membrane permeable cGMP analogues, which are poor activators of protein kinase A, are significantly less effective than STa or guanylin. In addition, elevation of cAMP levels by treatment with cholera toxin mimics the effects of ST. or guanylin. Taken together, these results strongly suggest that protein kinase A mediates the STa-or guanylin-induced inhibition of the taurine transporter activity in these cells.
In conclusion, the present study shows that the catalytic function of the taurine transporter in Caco-2 cells is regulated by cGMP-dependent cellular processes via protein kinase A. The levels of cGMP in these cells are elevated by STa, an enterotoxin produced by certain strains of E. coli or by guanylin, an endogenous peptide. These results suggest that infection with enterotoxigenic E. coli may lead to impaired intestinal absorption of taurine. Since the intestinal uptake of taurine is coupled to sodium uptake (Na+/taurine coupling ratio for the uptake process is 2 or 3), the inhibition of the activity of the taurine transporter might represent at least one of the mechanisms by which STa leads to defective intestinal sodium absorption. It has to be noted however that the quantitative significance of the contribution of the Na + -taurine cotransport process to the intestinal absorption of Na+ varies widely among individuals depending upon the diet. While some dietary constituents (e.g., vegetables) contain very little taurine, some others (e.g., meat, fish) may contain as high as 50 mM taurine. The present study also shows that cholera toxin, a diarrheagenic factor produced by Vibrio cholerae, impairs taurine uptake in Caco-2 cells, strongly implying that intestinal absorption of taurine may be impaired in cholera. Implications of these findings to the taurine status of infants and young children, an age group in which the prevalence of infection with enterotoxigenic E. coli and V. cholerae is high, are readily apparent because of the critical role of intestinal absorption in the maintenance of taurine nutrition in this population.
